Press Release

Posted: September 19, 2012 at 1:14 pm

Research and MarketsPosted on:19 Sep 12

Research and Markets (http://www.researchandmarkets.com/research/t8mv4n/global_psoriasis) has announced the addition of the "Global Psoriasis Drug Pipeline Capsule - 2012 Update" report to their offering.

Fore Pharma's latest report 'Global Psoriasis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Psoriasis market. It covers active Psoriasis pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Key Topics Covered:

1. Psoriasis - Disease Overview

2. Psoriasis Pipeline Overview

3. Psoriasis Phase 3 Clinical Trial Pipeline Insights

4. Psoriasis Phase 2 Clinical Trial Pipeline Insights

Read more:
Press Release

Related Posts